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ABSTRACT: Evidence is presented that the performance of
the rationally designed MALDI matrix 4-chloro-α-cyanocin-
namic acid (ClCCA) in comparison to its well-established
predecessor α-cyano-4-hydroxycinnamic acid (CHCA) is
signiﬁcantly dependent on the sample preparation, such as
the choice of the target plate. In this context, it becomes clear
that any rational designs of MALDI matrices and their
successful employment have to consider a larger set of
physicochemical parameters, including sample crystallization
and morphology/topology, in addition to parameters of basic
(solution and/or gas-phase) chemistry.
In recent years, matrix-assisted laser desorption/ionization(MALDI)1 has undergone some exciting developments,
often based on the introduction of new matrices and/or sample
preparations. New matrix systems, such as high-performing
liquid MALDI matrices,2−9 as well as the further development
of commonly employed matrices for solid MALDI sample
preparations10−13 have been two areas of increased interest.
The former has enabled the production of long-lasting and
high-yielding analyte ion signals,4,5,14 in some cases even the
production of predominantly multiply charged MALDI ions,4
while the latter has shown that by rational matrix design current
limits of sensitivity, based on well-established matrices for solid
MALDI, can be the subject for substantial further improve-
ments.11,12
For analytical techniques, in particular for mass spectrometric
techniques, sample preparation protocols and thus the sample’s
constitution can often widely vary. Consequently, this can
result in a rich source of variations in analytical performance.
Many parameters can inﬂuence these variations of performance,
with their exact eﬀect depending on the given conditions. In the
case of MALDI MS, it is often observed that sample
preparation has a major eﬀect on the outcome of the recorded
ion signal. At the sample preparation, parameters such as
relative humidity, temperature, air ﬂow, and target surface can
substantially inﬂuence the MALDI sample, such as the matrix/
analyte cocrystallization, and thus the resulting desorption and
ion formation processes and ultimately the analyte ion signal
intensities.
With this in mind, we have revisited the most promising of
the above-mentioned rationally designed MALDI matrices, 4-
chloro-α-cyanocinnamic acid (ClCCA),11,12,15 and compared it
with its close relative, the well-established α-cyano-4-hydroxy-
cinnamic acid (CHCA), which has been the matrix of choice
for decades in MALDI MS, mainly for the analysis of peptides.
For MALDI sample preparation, two diﬀerent targets
(ground stainless steel and AnchorChip) and diﬀerent
protocols were employed. The matrix solution preparations
used were essentially the ones published by Leszyk (Leszyk
preparation I and II) and the AnchorChip-speciﬁc protocol was
the one recommended by Bruker in their instrument manual
for the use of CHCA as matrix (Bruker preparation). For the
Bruker preparation, the CHCA or ClCCA matrix solution was
prepared at 1 mg/mL in 85% acetonitrile/0.1% TFA. The
Leszyk preparation I is speciﬁc for CHCA, which was prepared
at 5 mg/mL in 50% acetonitrile/0.1% triﬂuoroacetic acid
(TFA), while the Leszyk preparation II is speciﬁc for ClCCA,
which was prepared at 5 mg/mL in 80% acetonitrile/0.1% TFA.
MALDI sample preparation on AnchorChip targets involved
making up a bulk MALDI sample solution by mixing the
prepared matrix solution with the analyte solution in a ratio of
200:1 (v/v) unless otherwise reported. Aliquots of 1 μL of this
bulk solution were then spotted on AnchorChip targets in
triplicates. On ground steel targets, dried droplet (DD) sample
preparations were prepared by spotting 0.5 μL of matrix
solution ﬁrst on the target and adding 0.5 μL of (diluted)
analyte solution immediately afterward. In general, all MALDI
samples were allowed to dry under ambient conditions for 45
min.
The analytes used for this study were a peptide standard
mixture (cat. no. 222570; Bruker UK, Coventry, UK) and a
bovine serum albumin tryptic digest (cat. no. PS-204-1; Protea
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Biosciences, Morgantown, WV, USA). Mass spectra were
acquired on an Ultraﬂex TOF/TOF mass spectrometer (Bruker
UK) in positive ion reﬂectron mode using a nitrogen laser
emitting at 337 nm with a repetition rate of 50 Hz and on a
MALDI Q-TOF Premier mass spectrometer (Waters, Wilm-
slow, UK) in positive ion V mode using a laser emitting at 337
nm with a repetition rate of 20 Hz. For the TOF/TOF data
acquisition, each mass spectrum resulted from the accumulation
of data acquisitions from 5 diﬀerent desorption spots with 200
single laser shots each, while for the Q-TOF data acquisition
each mass spectrum resulted from the data accumulation of MS
scans over 1 min (i.e., 1200 laser shots) at a scan rate of 1 scan
per second. Laser ﬂuences on the instruments were optimized
in each case for the highest analyte signal-to-noise ratio (S/N).
For the BSA digest analyses, peaks were picked using the
SNAP algorithm in the FlexAnalysis software (version 3.0;
Bruker UK) with a S/N threshold of 3, a maximum number of
300 peaks, a TopHat baseline subtraction, and “Averagine” for
the SNAP average composition. The peak lists were then
searched using the peptide mass ﬁngerprint search routine of
the search engine Mascot 2.4 (Matrix Science Ltd., London,
UK). The search parameters were 100 ppm for peptide mass
tolerance, 1 for peptide charge state, trypsin for enzyme,
carbamidomethyl (C) for ﬁxed modiﬁcations, oxidation (M) for
variable modiﬁcations, and 1 for max missed cleavages.
Our initial objective was to improve the overall MALDI MS
performance by combining AnchorChip targets with the use of
the recently introduced matrix ClCCA and thus exploiting their
combined increase in peptide ion signal intensity. However,
when we used the sample preparation for AnchorChip targets
as recommended by the manufacturer (Bruker preparation) for
a comparison between the two matrices CHCA and ClCCA,
the results showed no advantage using ClCCA. In fact, the
average S/N for most of the peptides (7 out of 9) of the
peptide standard mixture analyzed at the 20 fmol level was
higher for CHCA with some signiﬁcantly higher ion signals for
bradykinin and substance P (see Table 1). Employing a higher
ClCCA concentration (5 mg/mL) in the matrix solution or a
diﬀerent mix ratio of analyte to matrix solution (1:1; v/v) as
reported for some DD sample preparations using ClCCA and
ground stainless steel targets did not result in any substantial
improvements (see Figure S-1, Supporting Information). In
most cases, these sample preparations actually worsened the
analytical performance as one would expect for using sample
Table 1. MALDI MS Analyte Ion S/N for Nine Peptides (20 fmol Each) Obtained from Samples Prepared on an AnchorChip or
Ground Steel Target Plate Using CHCA or ClCCA as MALDI Matricesa
average signal-to-noise ± SDb
TOF/TOF with AnchorChip target TOF/TOF with ground steel target Q-TOF with ground steel target
CHCA ClCCA CHCA ClCCA CHCA ClCCA
bradykinin (1−7) (m/z = 757.4) 299 ± 93 132 ± 70 249 ± 131 145 ± 65 115 ± 60 224 ± 103
angiotensin II (m/z = 1046.5) 1304 ± 409 1158 ± 323 511 ± 115 1013 ± 725 119 ± 25 875 ± 361
angiotensin I (m/z = 1296.7) 865 ± 248 579 ± 132 339 ± 100 300 ± 127 84 ± 19 265 ± 91
substance P (m/z = 1347.7) 1309 ± 367 431 ± 129 94 ± 17 515 ± 130 48 ± 15 397 ± 140
bombesin (m/z = 1619.8) 387 ± 175 145 ± 72 169 ± 63 621 ± 137 32 ± 11 367 ± 153
renin substrate (m/z = 1758.9) 128 ± 31 105 ± 39 50 ± 14 55 ± 8 21 ± 5 68 ± 20
ACTH clip (1−17) (m/z = 2093.1) 78 ± 38 86 ± 28 9 ± 2 27 ± 9 8 ± 2 37 ± 13
ACTH clip (18−39) (m/z = 2465.2) 6 ± 2 5 ± 1 5 ± 4 9 ± 4 2 ± 1 11 ± 4
somatostatin (m/z = 3147.5) 4 ± 2 5 ± 2 ND 5 ± 3 ND 7 ± 2
aData were acquired on a TOF/TOF and Q-TOF instrument, respectively. bSD standard deviation (n = 3).
Figure 1. MALDI mass spectra of peptide standards mixture (1 fmol on an AnchorChip target) acquired on an Ultraﬂex TOF/TOF mass
spectrometer using (a) CHCA and (b) ClCCA as matrix and the sample preparation protocol as recommended by the manufacturer. All observed
peptide analyte [M + H]+ ions are labeled with their recorded m/z and S/N values.
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preparations that are unconventional for AnchorChip targets.
Figure 1 demonstrates the lack of spectral improvement using
ClCCA on an AnchorChip target at the lower on-target level of
1 fmol. For most peptides, a higher S/N can be seen again
using CHCA compared to ClCCA.
Similar results were obtained with 1 fmol of BSA digest,
showing on average (n = 3) a signiﬁcantly higher Mascot score
for CHCA when protein identiﬁcation was undertaken by
peptide mass mapping using the Mascot search engine. Again,
S/N of BSA-matched peptides were in general ≥2−3 times
higher for CHCA compared to ClCCA samples. This result
together with the signiﬁcantly higher bradykinin ion signal for
CHCA was surprising as it was previously reported that ClCCA
exhibits a much lower discrimination eﬀect between arginine-
containing and other peptides, generally improving the
detection of peptides without arginine in mixtures with
arginine-containing peptides.
As the results obtained from the AnchorChip targets did not
show any improvement in using ClCCA compared to CHCA,
we next used ground steel target plates and employed MALDI
sample preparations as described in the literature in order to
verify earlier reports with respect to the advantages of using
ClCCA. These experiments were undertaken on two diﬀerent
mass spectrometers, a Q-TOF instrument with a medium
vacuum MALDI ion source and a TOF/TOF instrument with
the MALDI ion source under high vacuum. In all cases using
the ground steel targets, the sample preparations with ClCCA
improved the analyte ion signal-to-noise ratio, also leading to
improved protein identiﬁcation for the analysis of BSA by
Mascot peptide mass mapping. Table 1 lists the S/N values for
the measurements on both the Ultraﬂex TOF/TOF and Q-
TOF Premier instrument using a stainless steel target. Sample
preparations with ClCCA on stainless steel targets clearly
outperformed preparations with CHCA, in particular with
Figure 2. MALDI mass spectra of peptide standards mixture (20 fmol on a stainless steel target) acquired on a Q-TOF Premier mass spectrometer
using (a) CHCA (100% intensity = 457 counts) and (b) ClCCA (100% intensity = 1580 counts) as matrix and the sample preparation protocols for
each matrix as reported by Leszyk. All observed peptide analyte [M + H]+ ions are labeled with their recorded m/z and S/N values.
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respect to high molecular mass peptide ions as can be seen in
Figure 2.
The results obtained by using stainless steel targets are in
good agreement with the literature describing the advantages of
using ClCCA as a MALDI matrix. However, to the best of the
authors’ knowledge, there is only the report by Selman et al.16
comparing ClCCA with other MALDI matrices on AnchorChip
targets or other targets that generally improve MALDI MS
sensitivity using CHCA as matrix. Interestingly, this report
focuses on the comparison with DHB, a matrix that does not
beneﬁt as much as CHCA from the use of AnchorChip targets,
and on the analysis of glycans and glycopeptides, an analyte/
peptide subset known to be diﬃcult to analyze using the “hot”
matrix CHCA. Selman et al. predominately used normal
stainless steel target plates for the ClCCA-based samples in
their comparisons but AnchorChip targets for other matrices,
suggesting that also in their study AnchorChip targets did not
improve analytical sensitivity using ClCCA. Thus, despite the
well-demonstrated increase in analytical sensitivity by using
ClCCA as matrix in MALDI samples on stainless steel targets,
the same was not found for AnchorChip targets when
compared to CHCA. Although we have employed various
sample preparations with the use of AnchorChip targets, we
were not able to ﬁnd a sample preparation that led to better
analytical sensitivity using ClCCA compared to CHCA (using
the manufacturer’s recommended sample preparation proto-
col). It obviously remains to be seen whether an improved
ClCCA-speciﬁc sample preparation for the use of AnchorChip
targets can be found that will lead to a similar comparative
advance in analytical sensitivity as can be seen with stainless
steel targets.
In summary, it can be concluded that with the introduction
of newly designed matrix systems, showing increased (some-
times “best”) analytical performance for a given set of
experiments, a wider set of parameters needs to be investigated
before a new matrix system can be classiﬁed as an improvement
to currently available MALDI matrix systems. For ClCCA, it
appears to be true that it easily outperforms the established
matrices (e.g., CHCA) if prepared with the dried droplet
sample preparation method on normal stainless steel targets.
However, when prepared using more sophisticated sample
preparation methods (e.g., using AnchorChip targets), which
have been shown to further improve analytical performance
substantially for the well-established matrices, ClCCA’s
performance does not necessarily improve as much, losing all
the comparative advantage to other matrices that has previously
been reported under certain conditions.
Our results are a stark reminder that for all reports of new
MALDI matrices and matrix systems the utmost care needs to
be employed in concluding that a new matrix (as well as matrix
system, sample preparation, etc.) is a true advancement in
analytical performance. Ideally, as many performance-relevant
parameters as possible should be investigated with at least two
mandatory sets of experiments: (i) direct comparison of the
analytical performance using the respectively best method
(including sample preparation and data acquisition parameters)
for both the newly introduced system and the currently best
system available and (ii) a comparison with benchmark data at
the absolute level (e.g., absolute limits of detection and absolute
ion intensity levels) using all available sources, including data
acquired outside the inventor’s lab (e.g., literature data). Finally,
in the context of the latter, it should become compulsory that
any record-breaking limits of detection, particularly beyond the
femtomole level, should only be acceptable if the measurements
have been performed on new (previously unused) targets and/
or analytes that are not normally used in the lab. These
measures would signiﬁcantly reduce the inﬂuence of residual
analyte material from previous experiments on the reported
analyte ion signal intensity, thus providing a much greater
conﬁdence in the reported limit of detection.
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